Outsourcing has proven to be valuable to biopharmaceutical companies of all sizes. And different types of drug makers, from virtual biotechs to Big Pharma, have implemented outsourcing programs for a variety of reasons. There are commonalities in both outsourcing motivations and practices across the various buyer groups, as well as differences. Knowing which services are outsourced by your peers, as well as which factors are most relevant to their outsourcing strategy, may add value to your organization’s 2014 planning and future outsourcing initiatives.
The latest industry trends and proprietary data from Nice Insight survey results